High Levels of SOX5 Decrease Proliferative Capacity of Human B Cells, but Permit Plasmablast Differentiation

Currently very little is known about the differential expression and function of the transcription factor SOX5 during B cell maturation. We identified two new splice variants of SOX5 in human B cells, encoding the known L-SOX5B isoform and a new shorter isoform L-SOX5F. The SOX5 transcripts are highly expressed during late stages of B-cell differentiation, including atypical memory B cells, activated CD21low B cells and germinal center B cells of tonsils. In tonsillar sections SOX5 expression was predominantly polarized to centrocytes within the light zone. After in vitro stimulation, SOX5 expression was down-regulated during proliferation while high expression levels were permissible for plasmablast differentiation. Overexpression of L-SOX5F in human primary B lymphocytes resulted in reduced proliferation, less survival of CD138neg B cells, but comparable numbers of CD138+CD38hi plasmablasts compared to control cells. Thus, our findings describe for the first time a functional role of SOX5 during late B cell development reducing the proliferative capacity and thus potentially affecting the differentiation of B cells during the germinal center response.

[1]  Yan Liu,et al.  Expression and function of a novel isoform of Sox5 in malignant B cells. , 2014, Leukemia research.

[2]  D. Salvadori,et al.  Toxicogenomic activity of gemcitabine in two TP53-mutated bladder cancer cell lines: special focus on cell cycle-related genes , 2012, Molecular Biology Reports.

[3]  C. Rice,et al.  Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset. , 2011, Blood.

[4]  S. Brody,et al.  Transcriptional Regulation of an Axonemal Central Apparatus Gene, Sperm-associated Antigen 6, by a SRY-related High Mobility Group Transcription Factor, S-SOX5 , 2010, The Journal of Biological Chemistry.

[5]  C. Cunningham-Rundles,et al.  Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones. , 2010, Blood.

[6]  A. V. Morales,et al.  SOX5 controls cell cycle progression in neural progenitors by interfering with the WNT–β‐catenin pathway , 2010, EMBO reports.

[7]  Véronique Lefebvre,et al.  The SoxD transcription factors--Sox5, Sox6, and Sox13--are key cell fate modulators. , 2010, The international journal of biochemistry & cell biology.

[8]  M. Wegner.  All purpose Sox: The many roles of Sox proteins in gene expression. , 2010, The international journal of biochemistry & cell biology.

[9]  V. Gallo,et al.  The Yin and Yang of Sox proteins: Activation and repression in development and disease , 2009, Journal of neuroscience research.

[10]  G. Salles,et al.  Efficient and stable transduction of resting B lymphocytes and primary chronic lymphocyte leukemia cells using measles virus gp displaying lentiviral vectors. , 2009, Blood.

[11]  Anne-Kathrin Kienzler,et al.  B-cell activating factor receptor deficiency is associated with an adult-onset antibody deficiency syndrome in humans , 2009, Proceedings of the National Academy of Sciences.

[12]  K. Schwarz,et al.  Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells , 2009, Proceedings of the National Academy of Sciences.

[13]  A. Asplund,et al.  Sox5 can suppress platelet-derived growth factor B-induced glioma development in Ink4a-deficient mice through induction of acute cellular senescence , 2009, Oncogene.

[14]  V. Lefebvre,et al.  SOX5 postmitotically regulates migration, postmigratory differentiation, and projections of subplate and deep-layer neocortical neurons , 2008, Proceedings of the National Academy of Sciences.

[15]  M. Wegner,et al.  The transcription factor Sox5 modulates Sox10 function during melanocyte development , 2008, Nucleic acids research.

[16]  O. Ohara,et al.  Discriminating gene expression profiles of memory B cell subpopulations , 2008, The Journal of experimental medicine.

[17]  Wei Wang,et al.  Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals , 2008, The Journal of experimental medicine.

[18]  K. Cichutek,et al.  Targeted cell entry of lentiviral vectors. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  V. Lefebvre,et al.  L-Sox5 and Sox6 Drive Expression of the Aggrecan Gene in Cartilage by Securing Binding of Sox9 to a Far-Upstream Enhancer , 2008, Molecular and Cellular Biology.

[20]  P. Arlotta,et al.  SOX5 Controls the Sequential Generation of Distinct Corticofugal Neuron Subtypes , 2008, Neuron.

[21]  Kozo Nakamura,et al.  S100A1 and S100B, transcriptional targets of SOX trio, inhibit terminal differentiation of chondrocytes , 2007, EMBO reports.

[22]  Torsten Werner,et al.  SoxD proteins influence multiple stages of oligodendrocyte development and modulate SoxE protein function. , 2006, Developmental cell.

[23]  Kozo Nakamura,et al.  The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage. , 2004, Arthritis and rheumatism.

[24]  M. Nieto,et al.  LSox5 regulates RhoB expression in the neural tube and promotes generation of the neural crest , 2004, Development.

[25]  M. Wegner,et al.  Expression of Sox transcription factors in the developing mouse pancreas , 2003, Developmental dynamics : an official publication of the American Association of Anatomists.

[26]  Kozo Nakamura,et al.  Identification and characterization of the human long form of Sox5 (L-SOX5) gene. , 2002, Gene.

[27]  Xian-Yang Zhang,et al.  Lentiviral vectors for sustained transgene expression in human bone marrow-derived stromal cells. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[28]  V. Lefebvre,et al.  The transcription factors L-Sox5 and Sox6 are essential for cartilage formation. , 2001, Developmental cell.

[29]  R. Brady,et al.  Development of Multigene and Regulated Lentivirus Vectors , 2000, Journal of Virology.

[30]  J. Reiser.  Production and concentration of pseudotyped HIV-1-based gene transfer vectors , 2000, Gene Therapy.

[31]  Véronique Lefebvre,et al.  A new long form of Sox5 (L‐Sox5), Sox6 and Sox9 are coexpressed in chondrogenesis and cooperatively activate the type II collagen gene , 1998, The EMBO journal.

[32]  S. Karlsson,et al.  Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. Goodfellow,et al.  Cloning and characterization of SOX5, a new member of the human SOX gene family. , 1996, Genomics.

[34]  A. Ashworth,et al.  The Sry-related HMG box-containing gene Sox6 is expressed in the adult testis and developing nervous system of the mouse. , 1995, Nucleic acids research.

[35]  A. Ashworth,et al.  DNA binding and bending properties of the post-meiotically expressed Sry-related protein Sox-5. , 1994, Nucleic acids research.

[36]  A. Ashworth,et al.  An SRY‐related gene expressed during spermatogenesis in the mouse encodes a sequence‐specific DNA‐binding protein. , 1992, The EMBO journal.

[37]  V. Lefebvre,et al.  Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors. , 2007, The international journal of biochemistry & cell biology.

[38]  L. Moreland.  Complement receptor 2 , 2004 .

[39]  V. Lefebvre.  Toward understanding the functions of the two highly related Sox5 and Sox6 genes , 2002, Journal of Bone and Mineral Metabolism.